WeVote
Log In

Bill

Bill

HB 1152

Right to Try Medical Cannabis Act; create.

2026 Regular Session Introduced by Lee Yancey

Mississippi's HB 1152 establishes a right-to-try program enabling terminally ill patients to access medical cannabis outside standard regulatory approval processes.

Died In Committee
#publichealthandhumanservices #publichealthandwelfare
0
WeVote Research Nonpartisan
Bill Summary · HB 1152

Legislative bill overview

HB 1152 creates a "Right to Try" medical cannabis program in Mississippi, allowing patients with terminal illnesses to access cannabis products outside of standard clinical trials or FDA approval processes. The bill establishes a framework for eligible patients to obtain and use medical cannabis when conventional treatments have failed or are unavailable.

Why is this important

This legislation addresses a tension between patients seeking alternative treatments for life-threatening conditions and existing federal/state drug regulations. It could provide relief options for terminally ill patients while creating one of the earliest right-to-try cannabis programs in a conservative Southern state, potentially signaling shifting attitudes toward cannabis policy.

Potential points of contention

  • Federal-state conflict: Cannabis remains a Schedule I federal drug; state legalization doesn't resolve federal legal exposure for patients, providers, or the state
  • Patient safety concerns: Right-to-try programs bypass standard efficacy and safety testing; medical oversight and liability questions remain unresolved
  • Definition ambiguity: "Terminal illness" criteria, which patients qualify, and how cannabis products are regulated/sourced need clarification to prevent program expansion
  • Implementation gaps: The bill's passage through committee suggests approval, but details on licensing, product standards, and enforcement mechanisms may be underdeveloped

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.